Repositorio Dspace

Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat

Mostrar el registro sencillo del ítem

dc.contributor.author Wangesteen, Rosemary
dc.contributor.author Gómez-Guzman, Manuel
dc.contributor.author Banegas, Inmaculada
dc.contributor.author Rodríguez-Gómez, Isabel
dc.contributor.author Jiménez, Rosario
dc.contributor.author Duarte, Juan
dc.contributor.author García-Estañ, Joaquín
dc.contributor.author Vargas, Felix
dc.date.accessioned 2025-11-24T12:23:52Z
dc.date.available 2025-11-24T12:23:52Z
dc.date.issued 2022-06
dc.identifier.citation Wangensteen R, Gómez-Guzmán M, Banegas I, Rodríguez-Gómez I, Jiménez R, Duarte J, et al. Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat. Biomedicines. 25 de mayo de 2022;10(6):1230.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22133
dc.description.abstract This study investigated the vasoactive effects of des-aspartate-angiotensin-I (DAA-I) in male Wistar rats on whole body vascular bed, isolated perfused kidneys, and aortic rings. Dose-response curves to DAA-I were compared with those to angiotensin II (Ang II). The Ang II-type-1 (AT1) receptor blocker, losartan, was used to evaluate the role of AT1 receptors in the responses to DAA-I. Studies were also conducted of the responsiveness in aortic rings after endothelium removal, nitric oxide synthase inhibition, or AT2 receptor blockade. DAA-I induced a dose-related systemic pressor response that was shifted to the right compared with Ang II. Losartan markedly attenuated the responsiveness to DAA-I. DAA-I showed a similar pattern in renal vasculature and aortic rings. In aortic rings, removal of endothelium and nitric oxide inhibition increased the sensitivity and maximal response to DAA-I and Ang II. AT2 receptor blockade did not significantly affect the responsiveness to DAA-I. According to these findings, DAA-I increases the systemic blood pressure and vascular tone in conductance and resistance vessels via AT1 receptor activation. This vasoconstrictor effect of DAA-I participates in the homeostatic control of arterial pressure, which can also contribute to the pathogenesis of hypertension. DAA-I may therefore be a potential therapeutic target in cardiovascular disease.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/ *
dc.title Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35740253
dc.relation.publisherversion https://www.mdpi.com/2227-9059/10/6/1230
dc.identifier.doi 10.3390/biomedicines10061230
dc.journal.title Biomedicines
dc.identifier.essn 2227-9059


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta